Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer

Journal of Clinical Oncology

Volumn 17, Issue 3, 1999, Pages 894-901

  Flamen, Patrick ^a   Stroobants, Sigrid ^a   Van Cutsem, Eric ^a   Dupont, Patrick ^a   Bormans, Guy ^a   De Vadder, Nancy ^a   Penninckx, Freddy ^a   Van Hoe, Lieven ^a   Mortelmans, Luc ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER;

EID: 0033050819     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.3.894     Document Type: Article

References (19)

1. Cancer Facts and Figures: 1996. New York, NY, American Cancer Society, 1996
2. August DA, Ottow RT, Sugarbaker PH: Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3:303-324, 1984
3. Beart RW Jr: Colon and Rectum, in Abeloff MD, Armitage JQ, Lichter AS, et al (eds): Clinical Oncology. New York, NY, Churchill Livingstone, 1995, pp 1267-1286
4. Wanebo HJ, Chu QD, Vezeridis MP, et al: Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322-329, 1996
5. Delbeke D, Vitola JV, Sandler MP, et al: Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196-1201, 1997
6. 18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131:703-707, 1996
7. Schiepers C, Penninckx F, De Vadder N, et al: Contribution of PET in the diagnosis of recurrent colorectal cancer: Comparison with conventional imaging. Eur J Surg Oncol 21:517-522, 1995
8. 18F]fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 81:1666-1670, 1994
9. Pauwels E, McCready VR, Stoot JH, et al: The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 25:277-305, 1998
10. Dahlbom M, Hoffman EJ. Hoh CK: Whole-body positron emission tomography: I. Methods and performance characteristics. J Nucl Med 33:1191-1199, 1992
11. Shepp LA. Vardi Y: Maximum likelihood reconstruction for emission tomography. IEEE Trans Med Imaging 1:113-122, 1982
12. Lange K, Carson R: EM reconstruction algorithm for emission and transmission tomography. J Comput Assist Tomogr 8:306-316, 1984
13. Strauss LG. Clorius JH, Schlag P, et al: Recurrence of colorectal tumors: PET evaluation. Radiology 170:329-333, 1989
14. Ito M, Takashi K, Tadokoro M, et al: Recurrent rectal cancer and scar: Differentiation with PET and MR imaging. Radiology 182:549-552, 1992
15. Hiele M, Gevers AM, Mertens L, et al: Comparison of endorectal ultrasound and CT scan in the preoperative staging of colorectal cancer. Gastroenterology 114:A610, 1998(abstr)
16. Mascagni D, Corbellini L, Urciuoli P, et al: Endoluminal ultrasound for early detection of local recurrence of rectal cancer. Br J Surg 76:1176-1180, 1989
17. Thoeni RF: Gastrointestinal cancer: Radiologie diagnosis and staging. Radiol Clin North Am 35:457-485, 1997
18. Valk P. Abella-Columna E. Tesar D. et al: Detection of recurrent colorectal cancer by FDG-PET in patients with serum CEA elevation. J Nucl Med 39:135P, 1998 (abstr)
19. Strauss LG: Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients. Eur J Nucl Med 23:1409-1415, 1996